Treatment for pure red cell aplasia after major ABO‐incompatible allogeneic stem cell transplantation: a multicentre study-Reference-Cited by-同舟云学术

Treatment for pure red cell aplasia after major ABO‐incompatible allogeneic stem cell transplantation: a multicentre study

Published:2021-04-12 Issue:4 Volume:193 Page:814-826
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Longval Thomas¹^ORCID,Galimard Jacques‐Emmanuel²,Leprêtre Anne‐Claire³,Suarez Felipe⁴,Amiranoff Denise⁵,Cazaux Marine¹,Kaphan Eleonore¹,Michonneau David¹,Dhedin Nathalie¹,Coman Tereza⁶,Nguyen Quoc Stéphanie⁷,Peffault de Latour Régis¹,Resche‐Rigon Matthieu²⁸,Sicre de Fontbrune Flore¹

Affiliation:

1. Haematology Transplant Unit Saint‐Louis HospitalAssistance Publique‐Hôpitaux de Paris (APHP) ParisFrance

2. Centre of Research in Epidemiology and Statistics Sorbonne Paris CitéINSERMUMR‐1153ECSTRRA Team ParisFrance

3. Établissement Français du Sang (EFS) Saint‐Louis Hospital ParisFrance

4. Adult Haematology Department Necker‐Enfants Malades HospitalAssistance Publique‐Hôpitaux de Paris (APHP) ParisFrance

5. Établissement Français du Sang (EFS) Necker‐Enfants Malades Hospital ParisFrance

6. Haematology Department Gustave‐Roussy VillejuifFrance

7. Haematology Department La Pitié‐Salpêtrière Hospital ParisFrance

8. Biostatistics Unit SBIM, Saint‐Louis HospitalAssistance Publique‐Hôpitaux de Paris (APHP) Paris France

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17463

Reference70 articles.

1. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect

2. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation

3. ABO Blood Group Barrier in Allogeneic Bone Marrow Transplantation Revisited

4. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program

5. Impact of Donor-Recipient Major ABO Mismatch on Allogeneic Transplantation Outcome According to Stem Cell Source

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review;Frontiers in Oncology;2024-07-02

2. Immuno-Hematologic Complexity of ABO-Incompatible Allogeneic HSC Transplantation;Cells;2024-05-10

3. Umbilical Cord Blood and UC-MSCs Combined with Low-Dose Immunosuppressant in the Treatment of Elderly Patients with Pure Red Cell Aplastic: A Case Series;Current Stem Cell Research & Therapy;2024-05-02

4. Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report;Annals of Hematology;2024-04-01

5. Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data;Blood Advances;2024-03-28